Preclinical modeling of metabolic syndrome to study the pleiotropic effects of novel antidiabetic therapy independent of obesity.
Mochel JP, Ward JL, Blondel T, Kundu D, Merodio MM, Zemirline C, Guillot E, Giebelhaus RT, de la Mata P, Iennarella-Servantez CA, Blong A, Nam SL, Harynuk JJ, Suchodolski J, Tvarijonaviciute A, Cerón JJ, Bourgois-Mochel A, Zannad F, Sattar N, Allenspach K.
Mochel JP, et al. Among authors: blondel t.
Sci Rep. 2024 Sep 5;14(1):20665. doi: 10.1038/s41598-024-71202-y.
Sci Rep. 2024.
PMID: 39237601
Free PMC article.